Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication September 5, 2006
- Accepted for publication November 3, 2006
- Published online January 31, 2007.
Copyright & Usage
© 2007 by Society of Nuclear Medicine
Author Information
- Simon M. Ametamey 1 ,
- Valerie Treyer 2 ,
- Johannes Streffer 3 ,
- Matthias T. Wyss 2 ,
- Mark Schmidt 4 ,
- Milen Blagoev 1 ,
- Samuel Hintermann 4 ,
- Yves Auberson 4 ,
- Fabrizio Gasparini 4 ,
- Uta C. Fischer 3 and
- Alfred Buck 2
- 1Center for Radiopharmaceutical Science of ETH, PSI, and USZ, Department of Chemistry and Applied Biosciences of ETH, Zurich, Switzerland; 2PET Center, Division of Nuclear Medicine, University of Zurich, Zurich, Switzerland; 3Division of Psychiatric Research, University of Zurich, Zurich, Switzerland; and 4Novartis Institutes for Biomedical Research Basel, Novartis Pharma AG, Basel, Switzerland
- For correspondence or reprints contact: Simon M. Ametamey, PhD, Center for Radiopharmaceutical Science of ETH, PSI, and USZ, ETH-Hönggerberg, D-CHAB IPW HCI H427, Wolfgang-Pauli-Strasse 10, CH-8093 Zurich, Switzerland. E-mail: simon.ametamey{at}pharma.ethz.ch
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Plasma endocannabinoids in cocaine dependence and their interaction with cocaine craving and metabotropic glutamate receptor 5 density in the human brain
- Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies
- Characterization of Brain Dysfunction Induced by Bacterial Lipopeptides That Alter Neuronal Activity and Network in Rodent Brains
- Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation
- Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression
- PET Imaging of High-Affinity {alpha}4{beta}2 Nicotinic Acetylcholine Receptors in Humans with 18F-AZAN, a Radioligand with Optimal Brain Kinetics
- Probing the Metabotropic Glutamate Receptor 5 (mGlu5) Positive Allosteric Modulator (PAM) Binding Pocket: Discovery of Point Mutations That Engender a "Molecular Switch" in PAM Pharmacology
- 18F-FPEB, a PET Radiopharmaceutical for Quantifying Metabotropic Glutamate 5 Receptors: A First-in-Human Study of Radiochemical Safety, Biokinetics, and Radiation Dosimetry
- Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography
- CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor
- Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives
- Metabotropic Glutamate Subtype 5 Receptors Are Quantified in the Human Brain with a Novel Radioligand for PET
- Evaluation of the Metabotropic Glutamate Receptor Subtype 5 Using PET and 11C-ABP688: Assessment of Methods